We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Modular Hip System Offers New Features

By HospiMedica staff writers
Posted on 13 Sep 2006
A new modular hip system offers innovative features, including optimal sizing of the joint implant to more accurately match the implant to a patient's anatomy.

The Emperion modular hip system is intended for primary and revision total hip arthroplasty, and uses a titanium press-fit stem. More...
Innovative features of the implant include a circulotrapezoidal neck design that allows for a greater range of motion, a 50-micron hydroxyapatite layer applied onto the porous sintered-bead coating, and a bullet-tip shaped stem that reduces thigh pain and makes insertion of the device easier. The system feature easy-to-use, color-coded instrumentation to improve efficiency during the procedure.

Oxinium is based on a unique and advanced bearing product technology. It is created through a manufacturing process that enables zirconium alloy to absorb oxygen and transform to a ceramic on the surface, resulting in a material that incorporates the best features of ceramic and metal while avoiding the limitations associated with either material. The result is a revolutionary technology used in the production of components of knee and hip implants that exhibit superior performance characteristics due to the technology's hardness, low friction, and resistance to roughening and abrasion.

The Emperion hip system was developed by Smith and Nephew (Memphis, TN, USA). It is the only modular hip system that can be used with Smith & Nephew's proprietary Oxinium femoral heads.

"The Emperion system provides me with the versatility to reconstruct the hip joint in a simple, straight-forward manner, while still employing less invasive or tissue-preserving surgical techniques, said Dr. Bertrand Kaper of the Yavapai Medical Center (Prescott, Arizona, USA). "It takes the evolution of hip replacement surgery to the next level of clinical success.”



Related Links:
Smith and Nephew

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.